The table below shows Moderna, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
$19.26B
$18.47B
$803.00M
Cost of revenue
$868.00M
$1.46B
$4.69B
$5.42B
$2.62B
$8.00M
Gross profit
-
-
-
-
-
-
R&D
$3.13B
$4.54B
$4.84B
$3.29B
$1.99B
$1.37B
SG&A
MRNA annual revenue (10-K history)
Moderna, Inc. reported annual revenue of $1.94B for fiscal year 2025. That is down 39.9% from $3.24B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $108.40M (FY 2016) to $1.94B. Figures come from the company's audited annual reports as filed with the SEC.
